# E-Selectin Nasal Spray to Prevent Stroke Recurrence

> **NCT00012454** · PHASE2 · TERMINATED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 60 (—)

## Conditions studied

- Cerebrovascular Accident
- Transient Ischemic Attack

## Interventions

- **DRUG:** E-Selectin nasal spray

## Key facts

- **NCT ID:** NCT00012454
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-03
- **Primary completion:** —
- **Final completion:** 2004-02
- **Target enrollment:** 60 (—)
- **Last updated:** 2010-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00012454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00012454, "E-Selectin Nasal Spray to Prevent Stroke Recurrence". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00012454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*